Delivery Order SPE2DB22D2005-SPE2DB24FJHX3
- Not listed
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a for-profit organization and subsidiary of Amerisourcebergen Corporation, to provide COSENTYX SNRDY 300MG DOSE-2PENML pharmaceutical products. The delivery order, valued at $2,310.95, has an ultimate completion date of April 3, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31,...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract valued at $18,694.84 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distributor. The contract is for the supply of COSENTYX SNRDY 300MG DOSE-2PENML pharmaceutical products, with a completion date of February 5, 2024. This delivery order is issued under an indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp, valued...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $7,609.75 contract is for the supply of COSENTYX SNRDY 300MG DOSE-2PENML, a specialty pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded to Amerisourcebergen Drug Corp, which serves...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide COSENTYX SNRDY 300MG DOSE-2PENML pharmaceutical products. The contract has a ceiling value of $6,557.58 and a period of performance through April 4, 2024. This delivery order is issued under an existing indefinite delivery contract (IDC) between DLA and AmerisourceBergen Drug Corp, which has a potential value of up to...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract (SPE2DB24FK10L) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide COSENTYX SNRDY 300MG DOSE-2PENML pharmaceutical products. The contract has a ceiling value of $4,118.44 and a period of performance through April 10, 2024. This delivery order contract is issued under AmerisourceBergen Drug Corp's existing indefinite delivery contract (SPE2DB20D1110) with DLA,...
- The Defense Logistics Agency (DLA) awarded a $7,660.53 firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of COSENTYX SNRDY 300MG DOSE-2PENML pharmaceutical products. This delivery order falls under a $999,999,999.00 indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp, which serves as the primary contract vehicle for the company to provide pharmaceutical products and medical supplies to DLA...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $12,486.91 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution company. The contract is for the delivery of COSENTYX SNRDY 300MG DOSE-2PENML, a pharmaceutical product, with a period of performance ending on March 13, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) awarded by DLA to...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $24,296.40 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the supply of COSENTYX SNRDY 300MG DOSE-2PENML pharmaceutical products, with a performance period through April 8, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 awarded solely to AmerisourceBergen Drug...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical distribution company. The contract is for the supply of COSENTYX SNRDY 300MG DOSE-2PENML, a pharmaceutical product, to support military treatment programs and facilities. The contract has a potential value of $71,590.77 and a completion date of February 12, 2024. Amerisourcebergen Drug Corp is the prime...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract valued at $9,555.22 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of COSENTYX SNRDY 300MG DOSE-2PENML, a specialty pharmaceutical product. This order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded solely to Amerisourcebergen Drug Corp, which...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB24FJHX3Delivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of COSENTYX SNRDY 300MG DOSE-2PENML pharmaceutical products. The contract has a potential value of $8,675.27 and a completion date of February 20, 2024. Amerisourcebergen Drug Corp is the prime contractor, and no set-aside designation was used for this award. This delivery order is issued under Amerisourcebergen's existing indefinite delivery contract with DLA, which has a potential value of $999,999,999.00 and a performance period through December 31, 2025. The indefinite delivery contract serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.7k | 2/16/24 |